)
National Health Investors (NHI) investor relations material
National Health Investors Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
The July 1 NHC portfolio sale accelerated capital redeployment from skilled nursing toward private-pay senior housing and SHOP.
SHOP reached ~18% of total NOI including the October acquisition, up from 9% entering 2026; Q3 performance fell short of expectations amid occupancy and transition challenges.
Portfolio growth priorities are paired with a focus on operating execution, underperforming assets and disciplined investment.
Financial highlights
Q3 diluted EPS was $11.47 versus $0.69 YoY; net income attributable to common stockholders was $562.7M versus $32.8M, including a $541.6M NHC disposition gain.
Diluted NAREIT FFO was $1.12/share versus $1.09; diluted Normalized FFO was $1.12 versus $1.32. Q3 included $1.1M of abandoned-acquisition costs.
Q3 FAD was $57.1M versus $62.2M YoY; the payout ratio rose to 80.8% from 70.3%.
Lease revenue excluding specified non-cash items and reimbursements was $58.4M, down $12.9M YoY, mainly due to property disposals and properties moved to SHOP.
Q3 revenue was $113.5M versus $89.8M; resident fees and services rose to $47.7M from $21.2M as SHOP expanded.
Outlook and guidance
FY 2026 NAREIT and Normalized FFO guidance was revised to $4.68-$4.70/share; FAD guidance is $236.6M-$237.7M, with a $5M midpoint reduction.
Guidance assumes $190M of unidentified investments and existing commitments; total SHOP NOI is projected at $43.8M-$44.3M across 48 properties.
Same-store SHOP NOI growth guidance is 1%-3% for 15 properties in FY 2026 and 0%-1% for 26 properties in Q4.
Organic SHOP NOI growth objective remains high-single-digit to low-double-digit; Q4 holiday seasonality is expected to temper occupancy and near-term benefit.
Signed LOIs total $285.3M, including ~$190M expected to close in Q4; a further ~$400M pipeline is under evaluation, primarily SHOP.
- Q2 2026 featured strong SHOP growth, higher net income, and a major $560M portfolio sale.NHI
Q2 2026 - Strong 2025 results, strategic shift to private pay housing, and all proposals approved.NHI
AGM 2026 - Q1 2026 saw robust FFO growth, major SHOP expansion, and a $560M portfolio sale pending.NHI
Q1 2026 - $560M asset sale boosts private pay housing, deleverages, and simplifies governance.NHI
M&A Presentation - Annual meeting to vote on directors, executive pay, and auditor ratification for 2026.NHI
Proxy filing - 2025 saw robust growth, board refreshment, enhanced governance, and expanded ESG initiatives.NHI
Proxy filing - Strong SHOP and FFO growth in 2025; 2026 outlook supported by robust investments and industry trends.NHI
Q4 2025 - FFO and FAD rose on strong rent collections and occupancy, while net income declined 11%.NHI
Q2 2024 - Q4 and 2024 results surpassed guidance, with strong FFO, FAD, and SHOP growth and a positive 2025 outlook.NHI
Q4 2024
)
)
)
)
)
)
)
)